TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular Carcinoma
Clinical trial NCT04297280 · COMPLETED
Trial details
- NCT number
- NCT04297280
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-29
- Primary completion
- 2023-07-18
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.